Hepatocellular Carcinoma Market Size, Share, By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiotherapy, and Others), By Drug Class (Tyrosine Kinase Inhibitors (TKIs), Multikinase Inhibitors, Monoclonal Antibodies, Immunomodulators, and Others), By Distribution Channel ((Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and By Region - Trends, Analysis and Forecast till 2034

Innovation in Combination Therapies and Personalized Medicine:

• Continuous studies on combination therapies, namely, the combination of immunotherapy with targeted drugs or radiotherapy, are opening new treatment perspectives for HCC. Besides, personalized medicine-therapy tailored to a patient's genetic background and tumor characteristics also holds tremendous promise and opportunities for improving patient outcomes and broadening the market for precision therapies in HCC.